Acro Biomedical (ACBM) Total Current Liabilities (2015 - 2025)
Acro Biomedical's quarterly Total Current Liabilities came in at $401062.0 in Q4 2025, up 22.67% year-on-year from $326946.0 in Q4 2024, and down 8.21% quarter-over-quarter from $436942.0 in Q3 2025.
Acro Biomedical has reported Total Current Liabilities for 11 years, with the latest figure at $401062.0 in Q4 2025.
- For the quarter ending Q4 2025, Total Current Liabilities rose 22.67% year-over-year to $401062.0; the trailing twelve-month figure through Dec 2025 stood at $401062.0 (up 22.67% YoY), and the FY2025 full-year result was $401062.0, up 22.67% from the prior year.
- Total Current Liabilities for Q4 2025 stood at $401062.0, down from $436942.0 in the prior quarter.
- The five-year high for Total Current Liabilities was $436942.0 in Q3 2025, with the low at $60158.0 in Q2 2021.
- Average Total Current Liabilities over 5 years is $239881.0, with a median of $273607.5 recorded in 2023.
- Year-over-year, Total Current Liabilities slumped 78.71% in 2022 and soared 272.83% in 2023.
- Tracing ACBM's Total Current Liabilities over 5 years: stood at $91651.0 in 2021, then soared by 119.44% to $201116.0 in 2022, then soared by 43.49% to $288575.0 in 2023, then rose by 13.3% to $326946.0 in 2024, then grew by 22.67% to $401062.0 in 2025.
- The last three Total Current Liabilities figures came in at $401062.0 (Q4 2025), $436942.0 (Q3 2025), and $370797.0 (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | EQV Ventures Acquisition | 477.69 Mn | 477.69 Mn | - | 264,756.00 |
| 2 | Berto Acquisition | 316.66 Mn | 316.66 Mn | - | 885,401.00 |
| 3 | Centurion Acquisition | 311.94 Mn | 311.94 Mn | - | 155,870.00 |
| 4 | Churchill Capital Corp IX | 311.36 Mn | 311.36 Mn | - | 945,150.00 |
| 5 | Agriculture & Natural Solutions Acquisition | 301.94 Mn | 301.94 Mn | - | 17.33 Mn |
| 6 | Siddhi Acquisition Corp (Cayman Islands) | 286.76 Mn | 286.76 Mn | - | 175,750.00 |
| 7 | Bold Eagle Acquisition | 276.06 Mn | 276.06 Mn | - | 239,898.00 |
| 8 | Cartesian Growth Corp III | 270.68 Mn | 270.68 Mn | - | 1.39 Mn |
| 9 | Oyster Enterprises II Acquisition | 266.84 Mn | 266.84 Mn | - | 141,145.00 |
| 10 | Acro Biomedical | - | - | - | 401,062.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 401,062.00 |
| Sep 30, 2025 | 436,942.00 |
| Jun 30, 2025 | 370,797.00 |
| Mar 31, 2025 | 329,081.00 |
| Dec 31, 2024 | 326,946.00 |
| Sep 30, 2024 | 317,304.00 |
| Jun 30, 2024 | 308,029.00 |
| Mar 31, 2024 | 297,780.00 |
| Dec 31, 2023 | 288,575.00 |
| Sep 30, 2023 | 258,640.00 |
| Jun 30, 2023 | 199,494.00 |
| Mar 31, 2023 | 246,033.00 |
| Dec 31, 2022 | 201,116.00 |
| Sep 30, 2022 | 144,958.00 |
| Jun 30, 2022 | 81,456.00 |
| Mar 31, 2022 | 65,990.00 |
| Dec 31, 2021 | 91,651.00 |
| Sep 30, 2021 | 61,610.00 |
| Jun 30, 2021 | 60,158.00 |
| Mar 31, 2021 | 309,997.00 |
| Dec 30, 2020 | 312,185.00 |
| Sep 30, 2020 | 239,889.00 |
| Jun 30, 2020 | 171,268.00 |
| Mar 31, 2020 | 123,449.00 |
| Dec 31, 2019 | 111,541.00 |
| Sep 30, 2019 | 195,792.00 |
| Jun 30, 2019 | 133,091.00 |
| Mar 31, 2019 | 141,251.00 |
| Dec 31, 2018 | 103,075.00 |
| Sep 30, 2018 | 240,675.00 |
| Jun 30, 2018 | 232,788.00 |
| Mar 31, 2018 | 206,913.00 |
| Dec 31, 2017 | 172,976.00 |
| Sep 30, 2017 | 36,979.00 |
| Jun 30, 2017 | 30,664.00 |
| Mar 31, 2017 | 18,277.00 |
| Dec 31, 2016 | 24,597.00 |
| Sep 30, 2016 | 17,326.00 |
| Jun 30, 2016 | 11,007.00 |
| Mar 31, 2016 | 3,283.00 |
| Sep 30, 2015 | 825.00 |